3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
2
Stomach Neoplasms
1
Peritoneal Neoplasms
1
Gynecologic Cancer
1
Carcinoma, Ovarian Epithelial
1
Interventions
pembrolizumab
37
Paclitaxel
18
Cisplatin
18
Carboplatin
14
Nivolumab
13
Hyperthermic Intraperitoneal Chemotherapy
13
Docetaxel
11
Cyclophosphamide
11
Oxaliplatin
9
Irinotecan
9
Fluorouracil
9
atezolizumab
8
Trastuzumab
8
Leucovorin
8
Bevacizumab
8
fludarabine
7
Magnetic Resonance Spectroscopy
7
Specimen Handling
6
Ipilimumab
6
Gemcitabine
6
Mitomycin
5
Cytoreduction Surgical Procedures
5
Capecitabine
5
durvalumab
4
cemiplimab
4
aldesleukin
4
Taxes
4
Psychiatric Rehabilitation
4
Platinum
4
Drug Therapy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
genexol-PM
×
Gynecologic
×
Clear all
NCT03618758
2023-12-05
IPLUS
Seoul National University Bundang Hospital
Phase 1/2
Completed
35 enrolled